Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY28.81 CNY
Change Today +0.32 / 1.12%
Volume 19.4M
600062 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 04/28/15 All times are local (Market data is delayed by at least 15 minutes).

china resources double cra-a (600062) Snapshot

Open
CNY28.70
Previous Close
CNY28.49
Day High
CNY29.19
Day Low
CNY28.25
52 Week High
04/21/15 - CNY32.70
52 Week Low
05/19/14 - CNY16.26
Market Cap
16.5B
Average Volume 10 Days
15.8M
EPS TTM
CNY0.98
Shares Outstanding
571.7M
EX-Date
07/10/14
P/E TM
29.5x
Dividend
CNY0.34
Dividend Yield
1.19%
Current Stock Chart for CHINA RESOURCES DOUBLE CRA-A (600062)

Related News

No related news articles were found.

china resources double cra-a (600062) Related Businessweek News

No Related Businessweek News Found

china resources double cra-a (600062) Details

China Resources Double-Crane Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products and equipment in the People’s Republic of China and internationally. The company provides IV solutions; cardiovascular products, such as anti-hypertensive products; endocrinology related products comprising anti-diabetic drugs; and digestive system related products. It also provides anti-infection products comprising ofloxacin, levofloxacin, and synergic sulphonamide compound tablets; and Wen Wei Shu granules, Yang WEi Shu granules, Beijing Royal Jelly, and other products. The company is based in Beijing, the People’s Republic of China.

china resources double cra-a (600062) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

china resources double cra-a (600062) Key Developments

China Resources Double-Crane Pharmaceutical Co., Ltd., Board Meeting, Apr 17, 2015

China Resources Double-Crane Pharmaceutical Co., Ltd., Board Meeting, Apr 17, 2015. Agenda: To discuss and approve issues including the proposal of connected transaction of assets purchase through shares issuance and cash payment, the proposal of connected transaction constituted by assets purchase through shares issuance and cash payment and the proposal of signing relevant framework agreement on reorganization with transaction parties.

China Resources Double-Crane Pharmaceutical Co., Ltd. expected to report Q1 2015 results on April 27, 2015. This event was calculated by Capital IQ (Created on April 2, 2015).

China Resources Double-Crane Pharmaceutical Co., Ltd. expected to report Q1 2015 results on April 27, 2015. This event was calculated by Capital IQ (Created on April 2, 2015).

China Resources Double-Crane Pharmaceutical Co., Ltd. Reports Earnings Results for the Year 2014

China Resources Double-Crane Pharmaceutical Co., Ltd. reported earnings results for the year 2014. For the year, the company reported basic earnings per share of CNY 0.9479 and weighted average return on net assets of 9.87%.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600062:CH CNY28.81 CNY +0.32

600062 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600062.
View Industry Companies
 

Industry Analysis

600062

Industry Average

Valuation 600062 Industry Range
Price/Earnings 30.1x
Price/Sales 3.8x
Price/Book 2.9x
Price/Cash Flow 30.1x
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA RESOURCES DOUBLE CRA-A, please visit www.dcpc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.